gene_symbol
CD3E
hgnc_id
HGNC:1674
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Mosunetuzumab engages CD3ε on T cells to redirect them to CD20+ B cells; activated T cells kill CD20+ targets via perforin/granzyme. CD3ε+ T cells are effectors, not killed.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06015880
disease_id_num_tar_ref
5551
drug_id_num_tar_ref
15103